![Tolleiv Trimborn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Tolleiv Trimborn first degree
Entity | Entity type | Industry | |
---|---|---|---|
Enzyre BV
![]() Enzyre BV Packaged SoftwareTechnology Services Enzyre BV develops biochip platform that enzymatic reactions can be measured. The company is headquartered in Nijmegen, the Netherlands.
3
| Holding Company | Packaged Software | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tolleiv Trimborn via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PHARMING GROUP N.V. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
University of Tilburg | College/University | Graduate Degree | |
CELLECTIS S.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ACS Biomarker BV
![]() ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Director of Finance/CFO | |
First Dutch Capital BV
![]() First Dutch Capital BV Investment ManagersFinance First Dutch Capital BV is a company based in Amsterdam, Netherlands that was founded by Walter van Damme. The private company is focused on empowering human progress and is a family of companies that operate in the energy, health, and technology sectors. | Investment Managers | Corporate Officer/Principal | |
University of Antwerp | College/University | Doctorate Degree | |
Cergentis BV
![]() Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
Netherlands | 6 |
Belgium | 4 |
France | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Commercial Services | 2 |
Operational
Corporate Officer/Principal | 3 |
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Director of Finance/CFO | 2 |
Founder | 2 |
Most connected contacts
Insiders | |
---|---|
Dirk Pollet | 6 |
Guido Maertens | 5 |
Waander van Heerde | 1 |
- Stock Market
- Insiders
- Tolleiv Trimborn
- Company connections